Back to Search Start Over

Case report: Durable response after pembrolizumab in combination with radiation - induced abscopal effect in platinum - refractory metastatic endometrial clear cell carcinoma.

Authors :
Kao CH
Liu CT
Lin H
Huang YC
Lan J
Ou YC
Fu HC
Wu CH
Source :
Frontiers in immunology [Front Immunol] 2022 Dec 15; Vol. 13, pp. 1079253. Date of Electronic Publication: 2022 Dec 15 (Print Publication: 2022).
Publication Year :
2022

Abstract

Advanced endometrial clear cell carcinoma (CCC) tends to have poor prognosis owing to aggressive clinical behavior and poor response to conventional chemotherapy. Herein, we report a case of platinum-refractory recurrent ECCC successfully treated with the combination of pembrolizumab, localized radiotherapy and a few cycles of chemotherapy with an extremely durable response even after cessation of immunotherapy for 3 years at the time of publication.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Kao, Liu, Lin, Huang, Lan, Ou, Fu and Wu.)

Details

Language :
English
ISSN :
1664-3224
Volume :
13
Database :
MEDLINE
Journal :
Frontiers in immunology
Publication Type :
Report
Accession number :
36591227
Full Text :
https://doi.org/10.3389/fimmu.2022.1079253